Navigation Links
BP and Martek Biosciences Enter Joint Development Agreement to Deliver Advanced Biodiesels
Date:8/11/2009

; list-style-position: outside; list-style-image: url(/images_v4/bullet_solid2.gif); padding-left: 2em; margin-left: 2em; line-height: 1.5em;">
  • Access to a wide variety of biomass feedstocks such as sugarcane, sugarcane waste (bagasse), energy grass and woodchips, which can be produced at scale and in high yield.
  • Use of sustainable, non-food, plant biomass as its feedstock.
  • Ability to tailor the product for a variety of diesel and jet-fuel needs.
  • Reduced exposure to vegetable oil price.

  • Martek
    Martek Biosciences Corporation (NASDAQ: MATK) is a leader in the development and production of high-value oils from algae and other microbial sources. Martek's lead products are DHA and ARA oils developed and produced using patented technology. DHA omega-3 products promote health and wellness through every stage of life and ARA omega-6 products support growth and development in infants. The company produces life'sDHA™, a sustainable and vegetarian source of DHA omega-3 for use in foods, beverages, infant formula, and supplements, and life'sARA™, a sustainable and vegetarian source of ARA omega-6 for use in infant formula and growing-up milks. For more information on Martek Biosciences, visit www.martek.com. For more information on products containing life'sDHA and life'sARA, visit www.lifesdha.com.

    BP
    BP is of one of the world's largest energy companies, providing its customers with fuel for transportation, energy for heat and light, retail services and petrochemicals products for everyday items. It is the largest oil and gas producer in the U.S. and one of the largest refiners. BP also has a global network of around 22,000 service stations.

    BP is a leading player in the global biofuels market. In the
    '/>"/>

    Source: PRWeb
    Copyright©2009 Vocus, Inc.
    All rights reserved

    Page: 1 2 3 4

    Related biology technology :

    1. Martek to Announce Third Quarter 2007 Results on September 5, 2007
    2. Martek to Present at Upcoming UBS Conference
    3. Martek Signs Multi-Year Worldwide Sole Source Supply Agreement with Abbott
    4. Martek Announces Settlement of OmegaTech Milestone Litigation
    5. Martek to Obtain Permanent Injunction Against Lonza in U.S. Patent Infringement Suit; Jury Verdict on Infringement of Two of Three Patents Upheld by Judge
    6. European Patent Office Upholds Martek European DHA Food Patent; Scope of Original Claims Narrowed
    7. Martek to Present at Upcoming ThinkEquity Partners Conference
    8. Martek Announces Fourth Quarter and FY 2007 Financial Results
    9. Martek Signs DHA/ARA License and Supply Agreement With IlDong Foodis for Infant Formula in South Korea
    10. Leading DHA Expert and Former NIH Researcher, Dr. Norman Salem, Jr., to Join Martek as Chief Scientific Officer
    11. Challenge Spreadable Butter Now Features Marteks lifesDHA(TM)
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/24/2014)... Dec. 23, 2014 Vermillion, Inc. (Nasdaq: ... gynecologic disease, announced today that investors including Oracle ... Fund LLC and several Vermillion directors have agreed ... of Vermillion,s common stock and warrants to purchase ... private placement.  Under the terms ...
    (Date:12/24/2014)... Dec. 23, 2014 Sigma-Aldrich Corporation (NASDAQ: ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act ... on December 22, 2014, thereby completing the U.S. ... the acquisition of the Company by Merck KGaA, ... satisfies another condition to closing the transaction, which ...
    (Date:12/24/2014)... PARIS and NEW YORK ... data from its open-label pilot study of mazindol in ... Design, Development and Therapy in December 2014 . ... of mazindol in children with attention deficit/hyperactivity disorder" ( ... 2014 Dec 1;8:2321-2332. eCollection 2014 ) ...
    (Date:12/22/2014)... , Dec. 22, 2014   ... a developer of pathogen-specific therapies for serious ... protecting the microbiome, today announced positive topline ... 1a clinical trial of SYN-004, the Company,s ... of Clostridium difficile (C. difficile) ...
    Breaking Biology Technology:Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 4Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 5Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 3Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 2Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5
    ... , NEW YORK, Oct. 26 ... research report is available in its ... Bioinformatics and Computational Biology: Bottlenecks and ... http://www.reportlinker.com/p0156561/Reportlinker-Adds-Bioinformatics-and-Computational-Biology-Bottlenecks-and-Options.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire , The interdisciplinary ...
    ... Germany, October 26 Ziehm Imaging and BrainLAB,have ... intra-operative,guidance of pedicle screw and hardware placement during ... now allows,high-resolution 3D images from the Ziehm Vision2 ... surgical navigation driven by BrainLAB technology. Ziehm,s,Vision2 FD ...
    ... Pa., Oct. 26 Cadient Group , ... today announced that it has been recognized as one of ... the Greater Philadelphia region for the second consecutive year. ... during the five year period from 2004-2008. Cadient Group ...
    Cached Biology Technology:Reportlinker Adds Bioinformatics and Computational Biology: Bottlenecks and Options 2Reportlinker Adds Bioinformatics and Computational Biology: Bottlenecks and Options 3Ziehm Imaging and BrainLAB Improve Trauma and Spine Surgery With X-ray Based Navigation 2Ziehm Imaging and BrainLAB Improve Trauma and Spine Surgery With X-ray Based Navigation 3Ziehm Imaging and BrainLAB Improve Trauma and Spine Surgery With X-ray Based Navigation 4Ziehm Imaging and BrainLAB Improve Trauma and Spine Surgery With X-ray Based Navigation 5Cadient Group Ranks as Deloitte Fast 50 Company for Greater Philadelphia Region for Second Consecutive Year 2
    (Date:12/3/2014)... 2, 2014   Marvin Test Solutions , ... solutions for military, aerospace, and manufacturing organizations, today ... successful TS-900 PXI semiconductor test platform . ... high-end systems to customers at a fraction of ... traditional ATE. "Our semiconductor customers ...
    (Date:11/21/2014)... YORK , Nov. 19, 2014  Earlier this ... at New York College, and one of the most ... biosensor signals that are transmitted from Smartphones to third ... were Smartphones and has one of the earliest known ... discussing its usage in the military, child care, elder ...
    (Date:11/21/2014)... , Nov. 20, 2014   Atmel® Corporation ... microcontroller (MCU) and touch technology solutions, today launched the ... with the widest V cc range from ... accuracy and faster I 2 C bus communication speeds, ... EEPROM memory making them ideal for consumer, industrial, computer, ...
    Breaking Biology News(10 mins):Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4
    ... Calif. -- November 9, 2012 -- The Society of Environmental ... to Kevin Brix at the its 33rd Annual Meeting, November ... recently completed his Ph.D. at the Rosenstiel School of Marine ... has already made exceptional contributions to the understanding of fate ...
    ... November 2012: Scientists at the University of Liverpool ... the English Channel have the potential to affect the ... Channel Islands. The study by the University of ... Trust, funded by the Alderney Commission for Renewable Energy, ...
    ... International African Vaccinology Conference, Cape Town, South AfricaResults from ... in the New England Journal of Medicine , ... protect African infants against malaria. When compared to immunization ... first vaccination) vaccinated with RTS,S had one-third fewer episodes ...
    Cached Biology News:SETAC announces Chris Lee Award for metals research winner, Kevin Brix 2Gannets could be affected by offshore energy developments 2RTS,S malaria candidate vaccine reduces malaria by approximately one-third in African infants 2RTS,S malaria candidate vaccine reduces malaria by approximately one-third in African infants 3RTS,S malaria candidate vaccine reduces malaria by approximately one-third in African infants 4
    Rabbit polyclonal to Aortic Elastin ( Abpromise for all tested applications). entrezGeneID: 2006 SwissProtID: P15502...
    Anti-gp120/160(SIV/mac239) Immunogen: gp120(SIV/mac239) protein (Genebank accession #M33262)...
    Tropomyosin 4 [Tm4]...
    ...
    Biology Products: